CSF PKR Is a Diagnostic and Prognostic Marker in Alzheimer's Disease

被引：0
|
作者：
Hugon, Jacques [1 ]
Liger, Francois Mouton [1 ]
Dumurgier, Julien [1 ]
Laplanche, Jean Louis [1 ]
Paquet, Claire [1 ]
机构：
[1] Lariboisiere Fernand Widal Hosp, Memory Ctr, Paris, France
来源：
NEUROLOGY | 2013年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P03073
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Age and diagnostic performance of Alzheimer disease CSF biomarkers
    Mattsson, N.
    Rosen, E.
    Hansson, O.
    Andreasen, N.
    Parnetti, L.
    Jonsson, M.
    Herukka, S. -K.
    van der Flier, W. M.
    Blankenstein, M. A.
    Ewers, M.
    Rich, K.
    Kaiser, E.
    Verbeek, M. M.
    Rikkert, M. Olde
    Tsolaki, M.
    Mulugeta, E.
    Aarsland, D.
    Visser, P. J.
    Schroeder, J.
    Marcusson, J.
    de Leon, M.
    Hampel, H.
    Scheltens, P.
    Wallin, A.
    Eriksdotter-Jonhagen, M.
    Minthon, L.
    Winblad, B.
    Blennow, K.
    Zetterberg, H.
    NEUROLOGY, 2012, 78 (07) : 468 - 476
  • [32] CSF biomarkers in Alzheimer's disease
    Peskind, ER
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S8 - S8
  • [33] APP isoforms ratio in platelets: A peripheral diagnostic marker of Alzheimer's disease?
    Padovani, A
    Pastorino, L
    Bianchetti, A
    Perez, J
    Vignolo, L
    Lenzi, GL
    Trabucchi, M
    Cattabeni, F
    DiLuca, M
    ANNALS OF NEUROLOGY, 1997, 42 (03) : M44 - M44
  • [34] Cerebrospinal fluid tau protein as a potential diagnostic marker in Alzheimer's disease
    Arai, H
    Clark, CM
    Ewbank, DC
    Takase, S
    Higuchi, S
    Miura, M
    Seki, H
    Higuchi, M
    Matsui, T
    Lee, VMY
    Trojanowski, JQ
    Sasaki, H
    NEUROBIOLOGY OF AGING, 1998, 19 (02) : 125 - 126
  • [35] Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease
    Ishiguro, K
    Ohno, H
    Arai, H
    Yamaguchi, H
    Urakami, K
    Park, JM
    Sato, K
    Kohno, H
    Imahori, K
    NEUROSCIENCE LETTERS, 1999, 270 (02) : 91 - 94
  • [36] The PKR Activator PACT Is Induced by Aβ: Involvement in Alzheimer's Disease
    Paquet, Claire
    Mouton-Liger, Francois
    Meurs, Eliane F.
    Mazot, Pierre
    Bouras, Constantin
    Pradier, Laurent
    Gray, Francoise
    Hugon, Jacques
    BRAIN PATHOLOGY, 2012, 22 (02) : 219 - 229
  • [37] Diagnostic utility of the Clock Drawing Test and relationship with Alzheimer's disease CSF biomarkers
    Duro, D.
    Baldeiras, I.
    Lemos, R.
    Letra, L.
    Santiago, B.
    Santana, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 381 - 381
  • [38] Diagnostic accuracy of CSF Ab42 and florbetapir PET for Alzheimer's disease
    Mattsson, Niklas
    Insel, Philip S.
    Landau, Susan
    Jagust, William
    Donohue, Michael
    Shaw, Leslie M.
    Trojanowski, John Q.
    Zetterberg, Henrik
    Blennow, Kaj
    Weiner, Michael
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2014, 1 (08): : 534 - 543
  • [39] Diagnostic Validity Comparison Between Criteria Based on CSF Alzheimer's Disease Biomarkers
    Empar Blanco-Canto, Maria
    Monge-Argiles, J. A.
    Perez-Cejuela, C.
    Badia, C.
    Gabaldon, L.
    Munoz-Ruiz, C.
    Sanchez-Paya, J.
    Gasparini-Berenguer, R.
    Leiva-Santana, C.
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2017, 32 (02): : 101 - 107
  • [40] Diagnostic and Prognostic Laboratory Testing for Alzheimer Disease
    Winder, Zachary
    Wilcock, Donna
    Jicha, Gregory A.
    CLINICS IN LABORATORY MEDICINE, 2020, 40 (03) : 289 - +
12345